{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:50:38Z","timestamp":1764874238883,"version":"3.41.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jns.2025.123490","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:26:27Z","timestamp":1744302387000},"page":"123490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The safety and efficacy of left atrial appendage closure devices in patients with non-traumatic intracranial hemorrhage"],"prefix":"10.1016","volume":"473","author":[{"given":"Michael","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Koriesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar","family":"Killu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Sularz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric H.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Arsanjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fearghas","family":"O'Cochlain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaibhav","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Simard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Alkhouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Robert D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Scharf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2025.123490_bb0005","doi-asserted-by":"crossref","first-page":"1212161","DOI":"10.3389\/fcvm.2023.1212161","article-title":"Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies","volume":"10","author":"Franchin","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.jns.2025.123490_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.jns.2025.123490_bb0015","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"10.1016\/j.jns.2025.123490_bb0020","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jns.2025.123490_bb0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ana.25079","article-title":"Oral anticoagulation and functional outcome after intracerebral hemorrhage","volume":"82","author":"Biffi","year":"2017","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2025.123490_bb0030","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jns.2025.123490_bb0035","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jns.2025.123490_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11883-018-0733-y","article-title":"Anticoagulation resumption after intracerebral hemorrhage","volume":"20","author":"Li","year":"2018","journal-title":"Curr. Atheroscler. Rep."},{"issue":"6","key":"10.1016\/j.jns.2025.123490_bb0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.015735","article-title":"Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide cohort study","volume":"132","author":"Nielsen","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jns.2025.123490_bb0050","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/STROKEAHA.116.012945","article-title":"Use of antithrombotic therapy and long-term clinical outcome among patients surviving intracerebral hemorrhage","volume":"47","author":"Ottosen","year":"2016","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.jns.2025.123490_bb0055","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.hrthm.2016.05.016","article-title":"Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage","volume":"13","author":"Park","year":"2016","journal-title":"Heart Rhythm."},{"issue":"5","key":"10.1016\/j.jns.2025.123490_bb0060","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.thromres.2015.10.002","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage","volume":"136","author":"Witt","year":"2015","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.jns.2025.123490_bb0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/svn-2024-003142","article-title":"Left atrial appendage closure for patients with atrial fibrillation at high intracranial haemorrhagic risk","volume":"10","author":"Abramovitz Fouks","year":"2024","journal-title":"Stroke Vasc. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123490_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104685","article-title":"Left atrial appendage closure in patients with intracranial hemorrhage and nonvalvular atrial fibrillation","volume":"29","author":"Ajmal","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"3","key":"10.1016\/j.jns.2025.123490_bb0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10840-022-01141-z","article-title":"Left atrial appendage closure in patients with intracranial hemorrhage","volume":"64","author":"Garg","year":"2022","journal-title":"J. Interv. Card. Electrophysiol."},{"issue":"2","key":"10.1016\/j.jns.2025.123490_bb0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1212\/WNL.0000000000000022","article-title":"Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage","volume":"82","author":"Horstmann","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2025.123490_bb0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10840-019-00678-w","article-title":"WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage","volume":"59","author":"Hucker","year":"2020","journal-title":"J. Interv. Card. Electrophysiol."},{"issue":"5","key":"10.1016\/j.jns.2025.123490_bb0090","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.hrthm.2018.11.022","article-title":"Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage","volume":"16","author":"Hutt","year":"2019","journal-title":"Heart Rhythm."},{"issue":"7","key":"10.1016\/j.jns.2025.123490_bb0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hroo.2023.06.002","article-title":"Intracranial bleeding and associated outcomes in atrial fibrillation patients undergoing percutaneous left atrial appendage occlusion: Insights from National Inpatient Sample 2016-2020","volume":"4","author":"Khan","year":"2023","journal-title":"Heart Rhythm O2"},{"issue":"3","key":"10.1016\/j.jns.2025.123490_bb0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.11.126","article-title":"Left atrial appendage closure in patients with atrial fibrillation and previous intracerebral hemorrhage","volume":"26","author":"Renou","year":"2017","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2025.123490_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2017.02.042","article-title":"Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: results from the Amplatzer cardiac plug registry","volume":"236","author":"Tzikas","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.jns.2025.123490_bb0110","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.jns.2025.123490_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jns.2025.123490_bb0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12975-020-00838-5","article-title":"Left atrial appendage closure for patients with cerebral amyloid angiopathy and atrial fibrillation: the LAA-CAA cohort","volume":"12","author":"Schrag","year":"2021","journal-title":"Transl. Stroke Res."},{"issue":"1","key":"10.1016\/j.jns.2025.123490_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.jns.2025.123490_bb0130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7","article-title":"Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial","volume":"20","author":"So","year":"2021","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.jns.2025.123490_bb0135","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","article-title":"Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial","volume":"20","author":"Schreuder","year":"2021","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.jns.2025.123490_bb0140","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jcin.2022.12.006","article-title":"Peridevice leak after left atrial appendage occlusion: incidence, mechanisms, clinical impact, and management","volume":"16","author":"Alkhouli","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"issue":"6","key":"10.1016\/j.jns.2025.123490_bb0145","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.jns.2025.123490_bb0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjcard.2023.07.102","article-title":"Meta-analysis of the outcomes of peri-device leak after left atrial appendage closure","volume":"204","author":"Mostafa","year":"2023","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.jns.2025.123490_bb0155","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jns.2025.123490_bb0160","doi-asserted-by":"crossref","first-page":"e1048","DOI":"10.1212\/WNL.0000000000201664","article-title":"Association between statin use and intracerebral hemorrhage location: a nested case-control registry study","volume":"100","author":"Boe","year":"2023","journal-title":"Neurology"},{"issue":"24 Pt 2","key":"10.1016\/j.jns.2025.123490_bb0165","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1212\/01.wnl.0000296277.63350.77","article-title":"Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study","volume":"70","author":"Goldstein","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2025.123490_bb0170","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/STROKEAHA.119.027301","article-title":"Statins and risk of intracerebral hemorrhage in individuals with a history of stroke","volume":"51","author":"Ribe","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2025.123490_bb0175","unstructured":"Statins In Intracerbral Hemorrhage (SATURN) Clinical Trial. 2019 7\/2\/2024]."},{"key":"10.1016\/j.jns.2025.123490_bb0180","unstructured":"CHAMPION-AF Clinical Trial (CHAMPION-AF). 2020 6\/20\/20204 [cited 2024 6\/29\/2024]; 5\/19\/2020:[."},{"key":"10.1016\/j.jns.2025.123490_bb0185","unstructured":"The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4). 2023 7\/2\/2024]."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:59:23Z","timestamp":1747756763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":37,"alternative-id":["S0022510X25001078"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123490","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety and efficacy of left atrial appendage closure devices in patients with non-traumatic intracranial hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123490"}}